Ann: Proteomics International seeks FDA approval for PromarkerD, page-272

Gee, l just came in on the end of this thread. Promarker D flopping in any market is a major concern. l was under the impression ee had the diabetic predictive market cornered for the next 20 years. You know, the worlds most accurate predictive test for patients at risk of progressing to total renal failure with an accuracy of 86 percent. A test not only more accurate than whats currently available but considerably cheaper se well. So with all those credentials, how the F is Promarker D a flop? Have we got morons doing the marketing? Or is it that Covid 19 is taking up all the diagnostic space for the next F ing 5 years or longer with all the closet variants. If this stock is not well north of $ 2.00 dollars by December, l am gone. No time for dreamers and wanna bees. Get the job done Richard like we pay you for.